Identification of novel biomarkers for Parkinson's disease by metabolomic technologies (Q39026922)

8 September 2017

title

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies (English)

1 reference

8 September 2017

0 references

1 reference

5

Nobutaka Hattori

1 reference

8 September 2017

Taku Hatano

1

1 reference

8 September 2017

Shinji Saiki

series ordinal

2

1 reference

8 September 2017

Ayami Okuzumi

series ordinal

3

1 reference

8 September 2017

Robert P Mohney

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

20 March 2015

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

8 September 2017

published in

1 reference

8 September 2017

volume

87

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

295-301

1 reference

Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Unmet needs of patients with Parkinson's disease: interview survey of patients and caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Metabolomic profiling in LRRK2-related Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Tryptophan metabolism, from nutrition to potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Biochemical alterations associated with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Role of ergothioneine on S-nitrosoglutathione catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Ergothioneine protects against neuronal injury induced by β-amyloid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Parkinson's disease and pesticide exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Influence of polyamines on membrane functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Spermine: an anti-oxidant and anti-inflammatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Altered arginine metabolism in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-309676

21 January 2018

Identifiers

DOI

10.1136/JNNP-2014-309676

1 reference

8 September 2017

1 reference